Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide Articular Cartilage Cover

By Julie A. Vetalice

Geistlich Pharma Granted FDA Breakthrough Device Designation for Chondro-Gide Articular Cartilage Cover

Geistlich Pharma's Chondro-Gide® articular cartilage cover was granted an FDA Breakthrough Device Designation. Chondro-Gide collagen membrane is used in a single-step cartilage repair technique.

Geistlich Pharma Chondro-gide

Chondro-Gide Articular Cartilage Cover

The highly purified collagen membrane leverages the body’s own healing potential. It is used with bone marrow stimulation to treat defects.

More than 10 years of clinical success in Europe have shown the product to be a cost-effective single surgery treatment for repairing lesions with bone marrow stimulation techniques.

“The device is versatile and can be used in minimally invasive procedures where indicated,” said Carrie Hartill, Business Unit Director for Geistlich Surgery. “Cost effective, single surgery cartilage repair devices are not currently available in the USA, and Chondro-Gide® will fill this unmet clinical need.”

Product Labels: Orthobiologic Soft Tissue Repair

Tags: Regulatory